We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J's Risperdal Caused Boy's Breast Growth, Philly Jury Told

Law360, Philadelphia (January 23, 2015, 6:35 PM EST) -- A Philadelphia jury heard opening arguments Friday in a case accusing a Johnson & Johnson unit of failure to adequately warn an autistic Alabama boy’s mother and physicians about the risks of abnormal breast growth associated with the antipsychotic drug Risperdal.

Tom Kline, an attorney with Kline & Specter PC representing the family of 20-year-old Austin Pledger, said that Janssen Pharmaceuticals Inc. had worked for years to obscure evidence that Risperdal caused spikes in a hormone known as prolactin resulting in the abnormal growth of female breast tissue.

“We’re going to show you that Janssen knew all the time that he...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS